Notably, this was the firstly pooled analysis to verify the prognostic role of serum CYFRA 21-1 in the NSCLC patients treated with platinum-based chemotherapy or EGFR-TKIs. This evidence concerns the gene EGFR and non-small cell lung carcinoma.